Bristol-Myers Squibb Co
Change company Symbol lookup
Select an option...
BMY Bristol-Myers Squibb Co
XOM Exxon Mobil Corp
AMRC Ameresco Inc
ET Energy Transfer LP
AHCO Adapthealth Corp
LPSN LivePerson Inc
BGSF BGSF Inc
NEE Nextera Energy Inc
PSB-Y PS Business Parks Inc
ADBE Adobe Inc
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.

Premarket

Last Trade
Delayed
$55.38
-0.03 (-0.05%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$55.41
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
749

10-day average volume:
16,638,391
749

Display:

Providers:

UpdateCancel
4 providers
Yesterday's News, December 02, 2021
Bristol Myers Squibb Co. Stock Rises Thursday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) inched 0.84% higher to $55.41 Thursday, on what proved to be an all-around favorable trading session...(MarketWatch)

December 01, 2021
Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) advanced 2.46% to $54.95 Wednesday, on what proved to be an all-around grim trading session for the...(MarketWatch)

November 30, 2021
Bristol Myers Squibb Co. Stock Outperforms Market Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) slid 1.85% to $53.63 Tuesday, on what proved to be an all-around grim trading session for the stock...(MarketWatch)

November 29, 2021
Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) slipped 3.34% to $54.64 Monday, on what proved to be an all-around positive trading session for the...(MarketWatch)

November 24, 2021
Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) shed 1.11% to $56.81 Wednesday, on what proved to be an all-around mixed trading session for the...(MarketWatch)

Biotech Stock Roundup: Drug Approvals for BMRN, Updates From BIIB, BMY, MRNA & More

Drug approvals for BioMarin (BMRN) and regulatory updates from Biogen (BIIB), among others, have been the biotech sector's few key highlights during the past week. (Zacks)

November 23, 2021
Bristol Myers Squibb Co. Stock Outperforms Market On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) inched 0.72% higher to $57.45 Tuesday, on what proved to be an all-around positive trading session...(MarketWatch)

November 22, 2021
Bristol Myers Squibb Co. Stock Falls Monday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) slid 1.37% to $57.04 Monday, on what proved to be an all-around mixed trading session for the stock...(MarketWatch)

November 19, 2021
Bristol Myers Squibb Co. Stock Underperforms Friday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) shed 2.05% to $57.83 Friday, on what proved to be an all-around poor trading session for the stock...(MarketWatch)

Bristol Myers Squibb started at outperform with $72 stock price target at BMO Capital

(END) Dow Jones Newswires November 19, 2021 08:49 ET (13:49 GMT) (MarketWatch)

November 18, 2021
Bristol Myers Squibb Co. Stock Falls Thursday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) shed 0.67% to $59.04 Thursday, on what proved to be an all-around mixed trading session for the...(MarketWatch)

November 17, 2021
Bristol Myers Squibb Co. Stock Outperforms Market On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) inched 0.58% higher to $59.44 Wednesday, on what proved to be an all-around dismal trading session...(MarketWatch)

November 16, 2021
Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) slid 0.87% to $59.10 Tuesday, on what proved to be an all-around favorable trading session for the...(MarketWatch)

November 15, 2021
Bristol Myers Squibb Co. Stock Outperforms Market On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) inched 0.32% higher to $59.62 Monday, on what proved to be an all-around poor trading session for...(MarketWatch)

November 12, 2021
Bristol Myers Squibb Co. Stock Rises Friday, Still Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) inched 0.41% higher to $59.43 Friday, on what proved to be an all-around favorable trading session...(MarketWatch)

November 11, 2021
Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) slipped 0.34% to $59.19 Thursday, on what proved to be an all-around mixed trading session for the...(MarketWatch)

Compugen's stock jumps after Bristol Myers Squibb completes $20 million investment into the company

Shares of Compugen Ltd. (CGEN.TV) gained 13.4% in premarket trading on Thursday after Bristol Myers Squibb Co. (BMY) completed a $20 million investment in the company. Compugen's stock is down 48.1% so far this year, while the broader S&P...(MarketWatch)

November 10, 2021
Bristol Myers Squibb Co. Stock Falls Wednesday, Still Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) slid 0.12% to $59.39 Wednesday, on what proved to be an all-around dismal trading session for the...(MarketWatch)

November 09, 2021
Bristol Myers Squibb Co. Stock Rises Tuesday, Outperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) inched 0.08% higher to $59.46 Tuesday, on what proved to be an all-around dismal trading session for...(MarketWatch)

November 08, 2021
Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Bristol Myers Squibb Co. (BMY) dropped 0.07% to $59.41 Monday, on what proved to be an all-around great trading session for the...(MarketWatch)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.